Advanced Heart Failure and Transplant Cardiology · Phoenix, AZ
NPI
1356325690
Since 2005
Specialty
Advanced Heart Failure and Transplant Cardiology
Code 207RA0001X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
5779 E Mayo Blvd
Phoenix, AZ, 85054
Phone (480) 301-8000
Groups this clinician bills Medicare through
Medicare paid, 2024
$80K
1,864 services
Medicare patients, 2024
1,319
Average age 75
Drug cost, 2024
$6.9M
2,459 prescriptions
Company payments, 2025
$43K
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David E Steidley was code 93010 (electrocardiogram), 578 times for 535 patients. In total David E Steidley billed 1,864 services in 38 codes, and Medicare paid $80K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-09-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93010 Electrocardiogram | Facility | 578 | 535 | $6.04 | $3,491 |
| 93000 Electrocardiogram | Office | 479 | 473 | $10.15 | $4,861 |
| 99233 Hospital E&M - Subsequent | Facility | 167 | 61 | $90.74 | $15K |
| 99215 Office E&M - Established | Office | 142 | 115 | $127.53 | $18K |
| 99214 Office E&M - Established | Office | 126 | 107 | $92.32 | $12K |
| 99213 Office E&M - Established | Office | 41 | 38 | $66.17 | $2,713 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 24 | 20 | $12.68 | $304 |
| 99223 Hospital E&M - Initial | Facility | 23 | 23 | $130.97 | $3,012 |
| 93451 Percutaneous Transcatheterization | Facility | 21 | 20 | $97.24 | $2,042 |
| 99205 Office E&M - New | Office | 21 | 21 | $149.56 | $3,141 |
| 93010 Electrocardiogram | Office | 17 | 17 | $5.84 | $99.27 |
| 93505 Cardiovascular | Facility | 15 | 13 | $159.79 | $2,397 |
| 99204 Office E&M - New | Office | 15 | 15 | $119.58 | $1,794 |
| 99232 Hospital E&M - Subsequent | Facility | 14 | 12 | $60.18 | $842 |
By year: 2022 $60K for 698 services; 2023 $68K for 998 services; 2024 $80K for 1,864 services.
Medicare prescription drug claims, 2024
In 2024, the drug David E Steidley prescribed most often to Medicare patients was Entresto (Sacubitril/Valsartan), with 197 prescriptions and refills. In total David E Steidley wrote 2,459 Medicare prescriptions that cost $6.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Entresto Sacubitril/Valsartan | 197 | 409 | 53 | $266K |
| Jardiance Empagliflozin | 180 | 423 | 57 | $232K |
| Vyndamax Tafamidis | 169 | 181 | 22 | $4.2M |
| Carvedilol Generic | 137 | 357 | 51 | $1,333 |
| Atorvastatin Calcium Generic | 128 | 314 | 44 | $1,022 |
| Spironolactone Generic | 108 | 304 | 37 | $911 |
| Eliquis Apixaban | 106 | 240 | 36 | $138K |
| Eplerenone Generic | 105 | 260 | 37 | $7,523 |
| Losartan Potassium Generic | 83 | 226 | 30 | $675 |
| Tacrolimus Generic | 80 | 192 | 27 | $9,708 |
| Vyndaqel Tafamidis Meglumine | 70 | 70 | 11 | $1.5M |
| Rosuvastatin Calcium Generic | 69 | 192 | 24 | $1,238 |
| Torsemide Generic | 62 | 147 | 32 | $2,216 |
| Warfarin Sodium Generic | 55 | 130 | 13 | $1,069 |
| Amlodipine Besylate Generic | 54 | 128 | 19 | $227 |
Brand drugs: - claims; generic drugs: 1,592 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David E Steidley $43K ($43K in general payments such as food, travel and fees) from 8 companies. The largest payer was Alexion Pharmaceuticals, Inc. with $42K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.